Epigenetic suppression of the TGF-beta pathway revealed by transcriptome profiling in ovarian cancer

by Matsumura, N., Huang, Z., Mori, S., Baba, T., Fujii, S., Konishi, I., Iversen, E.S., Berchuck, A., Murphy, S.K.
Published 2014

Sorafenib efficacy in ovarian clear cell carcinoma revealed by transcriptome profiling

by Matsumura, N., Mandai, M., Okamoto, T., Yamaguchi, K., Yamamura, S., Oura, T., Baba, T., Hamanishi, J., Kang, H.S., Matsui, S., Mori, S., Murphy, S.K., Konishi, I.
Published 2014

The activated transforming growth factor-beta signaling pathway in peritoneal metastases is a potential therapeutic target in ovarian cancer

by Yamamura, S., Matsumura, N., Mandai, M., Huang, Z., Oura, T., Baba, T., Hamanishi, J., Yamaguchi, K., Kang, H.S., Okamoto, T., Abiko, K., Mori, S., Murphy, S.K., Konishi, I.
Published 2014

Histotype-specific copy-number alterations in ovarian cancer.

by Huang, R.Y, Gynaecology, National University Hospital, 5 Lower Kent Ridge Road, Singapore, 119074, Singapore, Chen, G.B., Matsumura, N., Lai, H.C., Mori, S., Li, J., Wong, M.K., Konishi, I., Thiery, J.P., Goh
Published 2020

An EMT spectrum defines an anoikis-resistant and spheroidogenic intermediate mesenchymal state that is sensitive to e-cadherin restoration by a src-kinase inhibitor, saracatinib (A...

by Huang, R.Y.-J., Wong, M.K., Tan, T.Z., Kuay, K.T., C Ng, A.H., Chung, V.Y., Chu, Y.-S., Matsumura, N., Lai, H.-C., Lee, Y.F., Sim, W.-J., Chai, C., Pietschmann, E., Mori, S., Low, J.J.H., Choolani, M., Thiery, J.P.
Published 2014

Functional genomics identifies five distinct molecular subtypes with clinical relevance and pathways for growth control in epithelial ovarian cancer

by Tan, T.Z., Miow, Q.H., Huang, R.Y.-J., Wong, M.K., Ye, J., Lau, J.A., Wu, M.C., Bin Abdul Hadi, L.H., Soong, R., Choolani, M., Davidson, B., Nesland, J.M., Wang, L.-Z., Matsumura, N., Mandai, M., Konishi, I., Goh, B.-C., Chang, J.T., Thiery, J.P., Mori, S.
Published 2014